Dr Daniel Sze Molecular Biology of Cervical Cancer; New Vaccines against Cervical Cancer - new Screeing Tests
Bottles of Merck & Co.'s cervical cancer vaccine Gardasil Source: Jb Reed/Bloomberg via Getty Images
Dr Daniel Man-Yuen Sze received his first PhD in immunology in UK. After nearly 2 decades dealing with Western medicine, Dr Sze decided to take up studies in Traditional Chinese Medicine. According to WHO, HPV types 16 and 18 are responsible for 70 % of all CC cases worldwide. The currently available vaccines against these two HPV types have the potential of reducing the incidence of cervical and anogenital cancer. As HPV cannot be propagated in tissue culture, and therefore, in most cases its accurate identification relies on molecular biology techniques. These techniques are going to be employed in Australia in future cervical cancer screening. Dr Sze also talks about why recombinant vaccines contain not only HPV types 16 and 18, but other types as well.
Share